Skip to main content

Table 2 Comparison of sociodemographic and clinical characteristics between type 2 diabetes patients with different MVCs

From: Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis

  MI only (n = 15,015) Stroke only (n = 11,738) MI and stroke (n = 2572) p*
n   n   n  
Men,  % 15,015 63.0 11,738 50.1 2572 60.6 <0.0001
Age (years) 15,015 72.4 (65.1;78.8) 11,738 74.8 (67.9;81.0) 2572 74.8 (68.5;80.4) <0.0001
Age at diagnosis (years) 15,015 60.9 (51.4;69.3) 11,738 63.9 (54.6;72.0) 2572 61.8 (52.0;70.0) <0.0001
Diabetes duration (years) 15,015 9.6 (3.9;16.2) 11,738 9.6 (4.2;15.2) 2572 11.0 (6.2;19.2) <0.0001
BMI (kg/m2) 13,887 29.2 (26.0;33.1) 9902 28.7 (25.5;32.7) 2255 29.1 (25.7;32.9) <0.0001
HbA1C (%) 13,795 6.9 (6.2;8.1) 10,889 7.0 (6.2;8.3) 2407 7.1 (6.3;8.3) <0.0001
Systolic BP (mmHg) 14,576 130.0 (120.0;140.0) 11,296 135.0 (120.0;149.0) 2496 130.0 (120.0;140.0) <0.0001
Diastolic BP (mmHg) 14,562 74.0 (70.0;80.0) 11,287 80.0 (70.0;80.0) 2496 75.0 (70.0;80.0) <0.0001
Total Chol (mg/dl) 12,750 166.0 (139.2;197.2) 8808 181.0 (150.0;216.0) 2087 169.0 (140.0;203.0) <0.0001
LDL-Chol (mg/dl) 12,086 94.0 (73.0;121.0) 8245 107.9 (82.0;138.0) 1997 96.0 (73.0;126.0) <0.0001
HDL-Chol (mg/dl) 12,176 41.0 (34.0;50.0) 8212 43.0 (35.0/52.0) 2001 41.0 (34.0;50.0) <0.0001
Physical inactivity,  % 5217 90.4 4869 94.5 1207 93.3 <0.0001
Smoking, yes,  % 12,049 10.0 9189 8.8 2210 9.2 0.0173
Cigarettes per day 1200 15 (10;20) 809 15 (10;20) 201 15 (10;20) 0.1579
  1. Data are medians (Q1;Q3) unless otherwise indicated
  2. * p values adjusted for multiple comparisons by FDR